About Athelas
                            Athelas develops technology to monitor chronically ill patients in their homes.                        
                                                    
                                    Headquarters
                                    Athelas, Mountain View
                                
                                                                                                
                                    Founded
                                    2016-06-01
                                
                                                                
                                                                
                                    Industry
                                    Biotechnology, Health Care, Life Science
                                
                                                                                                
                                    Last Funding Type
                                    Series C
                                
                                                                                                    
                                        Valuation
                                        9
                                    
                                                                                                
                                                                        Total Funding
                                    $150.13 million dollars
                                
                                                                                                
                                    IPO Status
                                    Private
                                
                                                            Financial
                                    Funding Rounds
                                    5
                                
                                                                                                
                                    Number of Lead Investors
                                    4
                                
                                                                                                
                                                                        Total Funding Amount 
                                    $150.13 million dollars
                                
                                                                                                
                                    Number of Investors
                                    20